ACT reports Q2 results on July 31 with options positioning at its most call-heavy in recent memory — a sharp contrast to the cautious hedging that typically precedes a financial sector earnings print.
The options signal is the clearest story heading into Thursday. The put/call ratio has collapsed to 0.065, more than two standard deviations below its 20-day average of 0.11, meaning call buyers are overwhelming put buyers by a wide margin. That degree of one-sided bullish positioning is unusual for a mortgage insurer, and it coincides with a stock that has already gained 5.4% on the week and 6% over the past month, closing at $47.97. The borrow market adds nothing alarming to the picture: availability is abundant at roughly 650% of shares short, cost to borrow is negligible at 0.50%, and short interest has drifted lower over the past month to 2.5% of the free float. There is no meaningful short squeeze dynamic in play.
The analyst consensus tells a more cautious story than the options market does. JP Morgan raised its target modestly to $46 on July 13 while holding its Neutral rating — leaving ACT trading above the Street's mean target of $46. BofA remains the most constructive voice, carrying a Buy rating with a $49 target set in April. RBC initiated coverage in late June at Sector Perform with a $46 target, adding another neutral voice to a consensus that has been gradually ratcheting targets higher without upgrading its conviction. The EV/EBIT factor score ranks in the 81st percentile, suggesting the valuation remains reasonable on an earnings-power basis even after the year-to-date run; the P/E sits near 9.9x, a modest multiple for a company that ranks in the 57th percentile on EPS surprise. EPS momentum scores, however, are weak — ranking in the 13th percentile on the 30-day measure and the 18th on 90-day — which means the forward earnings revision trend has not been supportive of the rally.
One structural feature worth noting is the ownership table. Genworth Financial holds nearly 80% of shares outstanding and has been steadily trimming its stake through monthly block sales — roughly 600,000 shares each in April, May, and June, totalling over $75 million in disposals over the past 90 days. This is a controlled secondary distribution rather than distress selling, but it represents a persistent, predictable supply overhang that the market has so far absorbed comfortably. Peers NMIH and MTG each gained around 1–2% on the week, broadly in line with ACT's move, suggesting the sector rather than company-specific factors has driven the recent strength.
The print on July 31 will test whether the underlying insurance operations — new insurance written, claims experience, and the trajectory of the loss ratio — can justify a stock price that now sits above the consensus analyst target, against a backdrop of call-heavy positioning that has already priced in good news.
See the live data behind this article on ORTEX.
Open ACT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
